Federal record
FDA Warning Letter issued December 12, 2025 · FDA closed it out on July 27, 2026. Read the FDA letter → Read the close-out letter →
Significant concerns: This provider has significant transparency or compliance concerns based on available public records. Evaluate the compliance data below before engaging their services.
MedisourceRx
Los Alamitos, CA
Is this your company? Claim this profile.
MedisourceRx is a compounding pharmacy. The FDA issued a warning letter involving MedisourceRx on December 12, 2025, closed out on July 27, 2026. Pricing was not publicly listed, so total cost should be confirmed before signing up.
What they offerCompounding Pharmacy
Why this score?
The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.
| 85-100 | High Confidence |
| 70-84 | Well Documented |
| 50-69 | Limited Confidence |
| 0-49 | Flagged |
MedisourceRx scores 40, in the Flagged band. The score moves when the public record changes. For MedisourceRx, the item most likely to move it: Pricing.
Payment never changes a score.
5 of 7 checks complete. The remaining checks have not been run yet. Missing checks reduce how complete the profile is. They are not a finding by themselves.
Score history
- 40September 2026Record updated
- 38May 2026
What we found on MedisourceRx
We reviewed FDA enforcement records, OIG exclusions, DEA registration, HIPAA breach records, NPI registration, PCAB accreditation, and FDA 503B registration.
The FDA issued a warning letter involving MedisourceRx on December 12, 2025, and closed it out on July 27, 2026. Read the details below. We could not independently verify a third-party certification or accreditation as of September 2026.
Why this score: 5 of 7 checks complete. Each links to the public source it was verified against.
A check we haven’t completed yet is not a mark against this provider. It just means we’re still sourcing that record. The score reflects what we’ve confirmed so far, and updates as more checks come in.
Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed September 14, 2026.
Our take
Vial EditorialBased on the records and public materials we reviewed.
The FDA issued a warning letter to MedisourceRx on December 12, 2025. FDA closed the case on July 27, 2026 after reviewing the company's corrections. The full history is in the source report.
Questions we’d want answered
Worth asking before you choose
Ask these before you sign up.
- 1What changed after the FDA warning letter?
- 2Has FDA issued a close-out letter?
- 3Are you operating as a 503A pharmacy or a 503B outsourcing facility?
- 4Which states are you licensed to ship to?
- 5Can you provide current state pharmacy license details?
See all 5 questionsShow fewer
Screenshot these or show your doctor: they’re the same questions Vial would ask.
Compare record details
MedisourceRx's FDA warning letter was closed out on July 27, 2026; Pacifica Pharmacy has a federal action on file (OIG exclusion).
| MedisourceRx | Pacifica Pharmacy | |
|---|---|---|
| Federal actions | Confirmed | Confirmed |
| Vial Score | 40/100 | 20/100 |
| LegitScript certified | No | No |
| PCAB accredited | No | No |
What Vial measures, and what we don’t
We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.
Other compounding pharmacy providers in Vial
Other Compounding Pharmacy in Vial’s directory. Open a profile, or compare side by side.
See 2 more alternativesShow fewer
Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.
Find your providerSide-by-side comparisons
More compounding pharmacy providers
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.